Article Text

PDF
Cooled ablation reduces pulmonary vein isolation time: results of a prospective randomised trial
  1. N Pérez-Castellano,
  2. J Villacastin,
  3. J Salinas,
  4. J Moreno,
  5. M Doblado,
  6. E Ruiz,
  7. R Isa,
  8. C Macaya
  1. Unit of Arrhythmias, Cardiovascular Institute, San Carlos University Hospital, Madrid, Spain
  1. Dr N Pérez-Castellano, Unidad de Arritmias, Instituto Cardiovascular, Hospital Clínico San Carlos, C/ Professor Martín Lagos s/n, 28040 Madrid, Spain; nperez.hcsc{at}salud.madrid.org

Abstract

Background: Currently, selection of the ablation catheter for pulmonary vein (PV) isolation is a matter of choice.

Objective: To evaluate the efficiency of cooled ablation for PV isolation.

Methods: A prospective randomised trial was carried out comparing the time required to disconnect each targeted PV using cooled ablation (open irrigation at 15 ml/min, group A) or standard temperature-controlled 4 mm tip catheter ablation (group B). The ablation parameter limit settings were 45°C, 35 (5) W in group A, and 55°C, 35 (5) W in group B.

Results: Thirty-six patients referred for a first atrial fibrillation (AF) ablation procedure were randomised to group A or group B (18 patients in each group). There were no significant differences in baseline characteristics between the groups. Bidirectional block was achieved in 61/61 PVs from group A (100%) and 59/61 PVs from group B (97%); p = NS. Time to PV disconnection was significantly shorter in group A than in group B (median (25th–75th centiles) 14 (5–28) min vs 19 (14–32) min, respectively; p = 0.003). Five asymptomatic PV stenoses were identified by MRI, all in group B (p = 0.05). After 1-year minimum follow-up, AF recurrences were less frequently documented in patients treated with cooled ablation (6% vs 33%; p = 0.05).

Conclusion: Cooled ablation is more efficient than standard ablation in achieving PV isolation. Results obtained from this study also suggest a potential benefit of clinical efficacy and safety from cooled ablation, which should be further evaluated in larger clinical trials.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Ethics approval: Ethics committee approval obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.